Comparison of Real Costs against the Price of INA-CBG's Ischemic Stroke in Bethesda Hospital

Muslimah Muslimah(1*), Tri Murti Andayani(2), Rizaldy Pinzon(3), Dwi Endarti(4)

(1) Doctoral Degree Program of Pharmaceutical Sciences, Unviersitas Gadjah Mada
(2) Faculty of Pharmacy, Universitas Gadjah Mada
(3) Faculty of Medicine, Universitas Gadjah Mada
(4) Faculty of Pharmacy, Universitas Gadjah Mada
(*) Corresponding Author


Stroke is the leading cause of death and disability that includes disability mild, moderate and severe need of maintenance costs high. The purpose of this research is to know the characteristics of the patient, the comparison of real costs and fares INA CBG's ischemic stroke inpatient and outpatient in Bethesda HOSPITAL Yogyakarta. This research was conducted with observational analytic approach with cross sectional design based on the perspective of the hospital. The subject of research that meets the criteria of inclusion as much as 96 patients. Criteria for Inclusion include patient JKN, ischemic stroke of the first offensive, onset of less than 24 hours and non of the references. Observation period 1 October 2015 sd 31 March 2016 inpatients were observed 6 months in retrospective. Secondary data research data are sourced on the medical record, IFRS, and Technology Unit of RS. Analysis of statistical data by the method of Mann Whitney and Kruskal Wallis. Based on the characteristics of long hospitalizations, inpatient class there is significant influence (p < 0.05) against ischemic stroke patients real costs of hospitalization. The total real costs RS ischemic stroke of Rp 993,181,170 to 96 111 patients with inpatient visits so that the cost of Rp 8,947,578 per episode of hospitalization. Furthermore the Total cost of stroke ischemic amounting to Rp 139,165,150 with 211 outpatient visits so that the cost of Rp 659,550 per an outpatient episode. Real costs RS ischemic stroke than outpatient rates INA CBG's-2014 have significant differences. Similarly the real costs of hospitalization compared to price of INA-CBG's 2014 have significant differences in class i. In conclusion Fund fares INA-CBG's either outpatient or inpatient insufficient finance the care of patients ischemic stroke in Bethesda hospital Yogyakarta.


Stroke Iskemik; Biaya Riil; Tarif INA-CBG’s; Ischemic Stroke; real costs; fares INA-CBG's

Full Text:



Omote Y, Deguchi K, Tian F, et al. Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol. Stroke. 2012;43(6):1639-1646. doi:10.1161/STROKEAHA.111.643098.

Organization WH. World Health Statistics 2015. Geneva: World Health Organization; 2015.

Chang K-C, Tseng M-C, Weng H-H, Lin Y-H, Liou C-W, Tan T-Y. Prediction of Length of Stay of First-Ever Ischemic Stroke. Stroke. 2002;33(11):2670-2674. doi:10.1161/01.STR.0000034396.68980.39.

Purbaningsih S, Wahyono D, Suparniati E. Cost of illness pasien stroke. J Manag Pharm Pract. 2015;5(2):95-103.

Pinzon Mkes dr R, Asanti SpS dr LA. Awas stroke! Pengertian, Gejala, Tindakan, Perawatan dan Pencegahan. Penerbit Andi; 2010.

Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517-584. doi:10.1161/STR.0b013e3181fcb238.

Segel JE. Cost-of-illness studies—a primer. RTI-UNC Cent Excell Heal Promot Econ. December 2006:1-39. congresso gramado/artigos/segel-2006.pdf.

Permenkes. PERMENKES Nomor 76 Tahun 2016 Tentang Pedoman INACBG Dalam Pelaksanaan JKN. September 2016.

Heeley E, Anderson CS, Huang Y, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009;40(6):2149-2156. doi:10.1161/STROKEAHA.108.540054.

Indonesia KKR. Peraturan Menteri Kesehatan Republik Indonesia Nomor 71 Tahun 2013 tentang Pelayanan Kesehatan pada Jaminan Kesehatan Nasional. Jakarta: Author. September 2013.

van Eeden M, van Heugten C, van Mastrigt G, van Mierlo M, Visser-Meily JMA, Evers S. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ Open. 2015;5(11):e008220.

WHO. Guidelines for estimating the economic burden of diarrhoeal disease. September 2005.

Firmansyah F, Andayani TM, Pinzon RT. Analisis biaya penyakit stroke iskemik. J Manag Pharm Pract. 2016;6(1):27-34. doi:10.22146/jmpf.235.

Feladita N, Satibi S, Marchaban M. Analisi biaya terapi stroke hemoragi pada pasien rawat inap. J Manag Pharm Pract. 2014;4(2):69-76. doi:10.22146/jmpf.269.

Ali MF, Aziz NA, Aznida FAA, Rizal AM, Azmin S. Prospective study of functional recovery of stroke patients at three months post admission: outcomes and implications for post sstroke care provision. Med Health. 2013;8(1):19–27.

Sugianto, Pinzon RT. Perbandingan angka mortalitas pasien stroke iskemik laki-laki dan perempuan di rs. Bethesda yogyakarta. December 2015.

Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94(1):16-26. doi:10.1136/hrt.2007.132951.

Shi G, Zhang Y, Geng C, et al. Profile and 1-Year Outcome of Ischemic Stroke in East China: Nanjing First Hospital Stroke Registry. J Stroke Cerebrovasc Dis. October 2015. doi:10.1016/j.jstrokecerebrovasdis.2015.08.032.

Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing. 2008;38(1):27-32. doi:10.1093/ageing/afn281.

Finkelstein EA, Chay J, Bajpai S. The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households. Mahal A, ed. PLoS One. 2014;9(6):e99572. doi:10.1371/journal.pone.0099572.

Budiarto W, Sugiharto M. Biaya klaim ina cbgs dan biaya klaim ina cbgs dan biaya riil penyakit katastropik rawat inap peserta jamkesmas di rumah sakit studi di 10 rumah sakit milik kementerian kesehatan januari–maret 2012. Bul Penelit Sist Kesehat. 2013;16(1 Jan).

Coleman CI, Straznitskas AD, Sobieraj DM, Kluger J, Anglade MW. Cost–Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable. Am J Cardiol. 2012;109(7):1020-1025. doi:10.1016/j.amjcard.2011.11.034.

Chow WL, Tin AS, Meyyappan A. Factors Influencing Costs of Inpatient Ischaemic Stroke Care in Singapore. Proc Singapore Healthc. 2010;19(4):283-291. doi:10.1177/201010581001900402.

Nur M, Sulong S. Direct medical cost of stroke: findings from a tertiary hospital in Malaysia. Med J Malaysia. 2012;67(5):473.

Huang Y-C, Hu C-J, Lee T-H, et al. The Impact Factors on the Cost and Length of Stay among Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2013;22(7):e152-e158. doi:10.1016/j.jstrokecerebrovasdis.2012.10.014.

ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: World Health Organization; 2011. http://files/657/ICD10Volume2_en_2010.pdf.

Transitional Islamic Government of Afghanistan Ministry of Health. National Medicine Policy. 2003:1-9.

Cheng C-L, Kao Y-HY, Lin S-J, Lee C-H, Lai ML. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236-242. doi:10.1002/pds.2087.


Article Metrics

Abstract views : 2621 | views : 13018


  • There are currently no refbacks.

Copyright (c) 2017 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats